v3.19.2
Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands |
3 Months Ended |
6 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income attributable to American Renal Associates Holdings, Inc. |
$ (572)
|
$ (734)
|
$ (23,659)
|
$ (3,802)
|
$ (4,898)
|
$ 7,496
|
$ (5,073)
|
$ (2,122)
|
$ 12,772
|
$ (7,073)
|
$ 6,521
|
$ (27,461)
|
$ (7,195)
|
$ (552)
|
$ (28,195)
|
$ 301
|
$ 12,220
|
$ (28,767)
|
$ (4,597)
|
$ 3,146
|
Change in the difference between the redemption values and estimated fair values for accounting purposes of the related noncontrolling interests |
|
(580)
|
(1,248)
|
497
|
|
559
|
(2,884)
|
(10,407)
|
(3,339)
|
(10,322)
|
0
|
(751)
|
(13,291)
|
(10,322)
|
(1,331)
|
(12,732)
|
(13,661)
|
(2,566)
|
(11,503)
|
(10,067)
|
Net income (loss) attributable to common shareholders |
|
$ (1,314)
|
$ (24,907)
|
$ (3,305)
|
|
$ 8,055
|
$ (7,957)
|
$ (12,529)
|
$ 9,433
|
$ (17,395)
|
$ 6,521
|
$ (28,212)
|
$ (20,486)
|
$ (10,874)
|
$ (29,526)
|
$ (12,431)
|
$ (1,441)
|
$ (31,333)
|
$ (16,100)
|
$ (6,921)
|
Weighted-average common shares outstanding (in shares) |
|
32,005,544
|
31,932,705
|
31,800,553
|
|
31,095,418
|
30,986,689
|
30,907,482
|
30,865,350
|
28,406,999
|
22,213,967
|
31,877,286
|
30,947,304
|
25,344,510
|
31,912,934
|
30,997,218
|
27,198,297
|
31,965,844
|
31,081,824
|
28,118,673
|
Weighted-average common shares outstanding, assuming dilution (in shares) |
|
32,005,544
|
31,932,705
|
31,800,553
|
|
33,833,822
|
30,986,689
|
30,907,482
|
31,436,814
|
28,406,999
|
22,785,670
|
31,877,286
|
30,947,304
|
25,344,510
|
31,912,934
|
30,997,218
|
27,198,297
|
31,965,844
|
31,081,824
|
28,118,673
|
Loss per share, basic and diluted (in USD per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (0.98)
|
$ (0.52)
|
$ (0.25)
|
Outstanding options excluded as impact would be antidilutive (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,442,048
|
1,894,340
|
572,097
|
X |
- DefinitionSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
+ Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareBasicAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
+ Details
Name: |
us-gaap_EarningsPerShareBasicAndDiluted |
Namespace Prefix: |
us-gaap_ |
Data Type: |
num:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
+ Details
Name: |
us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.
+ References
+ Details
Name: |
us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
+ Details
Name: |
us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
+ Details
Name: |
us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
|